WHO ICTRP trial
Phase II study on the safety and efficacy of cysteamine in association with…
EUCTR2019-002514-40-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-002514-40-IT |
|---|---|
| Public title | Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the host |
| Scientific title | Phase II study on the safety and efficacy of cysteamine in association with standard tuberculosis therapy for the treatment of patients with pulmonary tuberculosis: a new therapy for tuberculosis directed at the host - CISTA-TB |
| Primary sponsor | ISTITUTO NAZIONALE PER LE MALATTIE INFETTIVE "LAZZARO SPALLANZANI" |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Pulmonary Mycobacterium tuberculosis infection MedDRA version: 20.0 Level: PT Classification code 10037440 Term: Pulmonary tuberculosis System Organ Class: 10021881 - Infections and infestations ;Therapeutic area: Diseases [C] - Bacterial… |
| Interventions | Trade Name: CYSTAGON - 150 MG 100 CAPSULE FLACONE USO ORALE Product Name: Cystagon Product Code: [-] Pharmaceutical Form: Capsule, hard INN or Proposed INN: 00191501 CAS Number: 60-23-1 Current Sponsor code: - Concentration unit: mg… |
| Registration date | May 24, 2021 |
| Target size | 30 |
| Secondary IDs | CISTA-TB |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: